100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
Relebactam D9
● Auf Lager
| Katalog-Nr.:: | DVE002149 |
|---|---|
| CAS-Nr.:: | N/A |
| Summenformel:: | C12H11D9N4O6S |
| Molare Masse:: | 357.43 g/mol |
Zusätzliche Informationen zu
Parent drug
RelebactamIUPAC-Name
(1R,2S,5R)-7-oxo-2-((piperidin-4-yl-2,2,3,3,4,5,5,6,6-d9)carbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfatePharmacopeial Synonyms
N/ASynonyme
N/ASMILES
[2H]C1([2H])C([2H])([2H])C([2H])(NC(C2CC[C@H]3N(OS(=O)(O)=O)C([N@@]2C3)=O)=O)C([2H])([2H])C([2H])([2H])N1InChI
InChI=1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10?/m1/s1/i3D2,4D2,5D2,6D2,8DBeschreibung
Relebactam D9 impurity is an isotopically labeled variant characterized by substitution of nine hydrogens with deuterium, producing a nominal mass increase of approximately +9 Da relative to the parent species. It is detected as a distinct M+9 ion by LC-MS and exhibits attenuated 1H NMR signals with corresponding 2H NMR resonances, facilitating unambiguous identification and quantitation. Analytical characterization should include HRMS, LC-MS/MS and orthogonal NMR methods to determine incorporation level, positional distribution and residual protio content. Control strategies focus on synthesis optimization to minimize isotopic exchange, defined acceptance criteria in impurity profiles and stability testing to evaluate any impact on assay accuracy and regulatory compliance under ICH impurity guidelines.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Relebactam impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
